drugset / Trial / NCT00416702
Safety and Pharmacokinetics of Indacaterol in Healthy Subjects and Those With Impaired Liver Function
Non-randomizedParallel-groupOpen-labelTreatment
Summary
This study is designed to evaluate the safety and pharmacokinetic effects of indacaterol in subjects with impaired liver function in comparison with healthy subjects
Timeline
- Start
- 2006-11
- Primary completion
- —
- Completion
- 2008-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Indacaterol | Other / unclassified | 600 ug | — |